Arcturus therapeutics holdings inc. (ARCT)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19
OPERATING ACTIVITIES:
Net loss

-9,777

-10,989

-7,433

-685

-6,884

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

182

153

182

177

172

Share-based compensation expense

849

797

383

403

399

Loss from equity-method investment

163

-

-

-

288

Other non-cash expenses

-274

-

-

-

-212

Changes in operating assets and liabilities
Accounts receivable

172

-446

-3,192

1,360

-24

Prepaid expense and other assets

1,179

-1,853

930

752

291

Accounts payable

-2,276

1,666

716

-812

1,585

Accrued liabilities

1,746

243

2,968

524

-2,060

Deferred revenue

-1,668

-1,971

-1,832

11,629

1,144

Net cash used in operating activities

-11,858

-7,538

-2,836

9,340

-5,411

INVESTING ACTIVITIES:
Acquisition of property and equipment

142

315

159

266

78

Net cash used in investing activities

-142

-315

-159

-266

-78

FINANCING ACTIVITIES:
Proceeds from exercise of stock options

118

-

-

-

-

Net cash provided by financing activities

118

-

-

-

-

NET DECREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH

-11,882

-2,819

18,332

24,620

-5,489

Supplemental disclosure of cash flow information
Cash paid for interest

228

183

168

173

167

Non-cash investing activities
Right-of-use asset obtained in exchange for lease liabilities

674

0

0

0

5,868

Purchase of property and equipment in accounts payable

262

114

110

-119

135